Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
Clinical trial NCT00365222 · TERMINATED
Trial details
- NCT number
- NCT00365222
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2007-06-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.